These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 7587030
1. Review and reassessment of dosing schedules for cefotaxime in selected medical indications. Young LS. Diagn Microbiol Infect Dis; 1995; 22(1-2):147-54. PubMed ID: 7587030 [Abstract] [Full Text] [Related]
5. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections. Plosker GL, Foster RH, Benfield P. Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990 [Abstract] [Full Text] [Related]
6. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Rimola A, Navasa M, Arroyo V. Diagn Microbiol Infect Dis; 1995 Jan; 22(1-2):141-5. PubMed ID: 7587029 [Abstract] [Full Text] [Related]
10. Effect of frequency of administration on therapeutic efficacy of cefotaxime. Parker RH. Clin Ther; 1984 Jan; 6(4):488-99. PubMed ID: 6088045 [Abstract] [Full Text] [Related]
12. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. Boccazzi A, Tonelli P, Bellosta C, Careddu P. Diagn Microbiol Infect Dis; 1998 Dec; 32(4):265-72. PubMed ID: 9934543 [Abstract] [Full Text] [Related]
14. The role of cefotaxime in the treatment of surgical infections. Wittmann DH. Diagn Microbiol Infect Dis; 1995 Dec; 22(1-2):173-82. PubMed ID: 7587036 [Abstract] [Full Text] [Related]
18. Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections. Brogden RN, Spencer CM. Drugs; 1997 Mar; 53(3):483-510. PubMed ID: 9074846 [Abstract] [Full Text] [Related]